30 participants
A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-24
- Start Date:
- 2018-03-16
- Completion:
- 2020-12-19
Conditions
- Acute Myeloid Leukemia (AML)
Interventions
- DRUG
No Results Yet